Norovirus, formerly referred to as Norwalk virus, is the most common cause of epidemic nonbacterial gastroenteritis in the world.
The image below depicts the norovirus genomic structure and capsid domains.
Symptomatic norovirus gastroenteritis typically develops 24-48 hours after ingestion of contaminated food or water or after contact with an infected individual. The onset can be abrupt or gradual, but each episode is short-lived, lasting only 24-72 hours. Symptoms include the following:
Nausea and vomiting (profuse, nonbloody, nonbilious)
Watery diarrhea (nonbloody)
Low-grade fever is common: But temperatures may reach 38.9˚C
Myalgias and malaise
Focal tenderness and peritoneal signs are absent in abdominal examination. Vital signs in norovirus gastroenteritis include the following:
Possible hypotension with volume depletion
See Clinical Presentation for more detail.
Norovirus infection can be detected via the following studies:
Immune electron microscopy: Immune serum is used to aggregate virus in stool samples to aid detection
Antigen detection immunoassay: Has high sensitivity but low specificity because of reactivity with antigenic variants and homologous viruses
Nucleic acid amplification: Highly sensitive and specific 
Serum antibody titers can be detected within 2 weeks of illness. During norovirus infection, immunoglobulin M (IgM) to norovirus has been found to be more specific than IgG. 
Imaging for isolated, uncomplicated gastroenteritis is not required. In patients with severe symptoms in whom acute abdomen is suspected and in those with preexisting disorders such as inflammatory bowel disease, abdominal radiography or computed tomography scanning should be performed.
In January 2013, the US Centers for Disease Control and Prevention (CDC) reported that a new norovirus strain, GII.4 Sydney, which was first detected in Australia, had spread to the United States. During the last 4 months of 2012, GII.4 Sydney accounted for 53% of 266 norovirus outbreaks in the United States, with roughly half of them having resulted from direct person-to-person transmission and another 20% having been foodborne. In general, GII.4 strains are associated with higher rates of hospitalization and death. [3, 4]
See Workup for more detail.
Treatment of norovirus gastroenteritis includes the following:
Oral fluid and electrolyte replacement: Generally adequate for the treatment of norovirus infections
Intravenous fluid and electrolyte resuscitation: May be necessary in cases of severe volume depletion
Antiemetics: For relief of nausea and vomiting
Analgesics: For relief of myalgias and headache
Antiperistaltic agents: Should generally be avoided in cases of infectious diarrhea but can be considered in patients with severe diarrhea
Norwalk virus was officially renamed norovirus by the International Committee on Taxonomy of Viruses in 2002. The virions contain a single-stranded RNA molecule in round to hexagonal capsids that are 35-39 nm in diameter, with icosahedral symmetry. The surface structure of the capsid is a regular pattern with distinctive features and 32 cup-shaped depressions. [5, 6]
Norovirus was first recognized as a cause of gastroenteritis in 1972, when it was detected in stool samples collected from infected elementary school students and contacts during an outbreak in Norwalk, Ohio, in 1968. It was declared a member of the Caliciviridae family of viruses in 1993.  It is now considered the most common cause of epidemic nonbacterial gastroenteritis in the world.
In the 1970s and 1980s, typing of Norwalk-like virus (NLV) relied solely on immunologic methods involving human clinical samples as the source of antigens and antibodies. These methods had serious limitations in accuracy and reproducibility and never provided a reliable scheme for antigenic classification of strains. In the 1990s, however, newer molecular techniques to amplify, sequence, and express the genome of NLV strains allowed researchers to genetically and antigenically characterize NLV strains. 
The Norovirus genus contains more than 40 different strains that are divided into 5 genogroups based on sequence similarity. Viruses in genogroups I, II, and IV are primarily human pathogens, although genogroup II contains a porcine-specific virus. Viruses in genogroup III and V infect bovine and murine species, respectively. Each genogroup is further subdivided into genoclusters based on sequence similarity. 
The genome consists of single-stranded RNA of 7.3-7.7 kilobases. It encodes 3 open reading frames (ORFs). ORF 1 is the largest (approximately 1700 amino acids) and expressed as a nonstructural polyprotein precursor that is cleaved by the viral 3C-like protease. ORF 2 encodes the viral capsid (550 amino acids) and contains the shell and protruding domains. ORF 3 encodes a small basic protein of unknown function. See the image below.
Noroviruses are transmitted person to person via direct contact, exposure to aerosols, or fecal–oral routes. Noroviruses are highly contagious, with infection requiring fever than 10 virions (ID50 = 10 virions), leading to disease in 50% of inoculated individuals. The virus is extremely stable in the environment and resists freezing temperatures, heat (up to 60°C), disinfection with chlorine, acidic conditions, vinegar, alcohol, antiseptic hand solutions, and high sugar concentrations. The incubation period is approximately 1-2 days, and symptoms typically last 1-3 days (or longer in immunocompromised individuals). Viral shedding occurs for up to 3 weeks following infection. 
Noroviruses bind polymorphic histoblood group antigens (HBGAs) that putatively serve as receptors or cofactors for infection. Strains from different genoclusters bind various HBGAs: Genogroup I viruses preferentially bind blood group A and O antigens, while genogroup II viruses predominantly bind A and B antigens.  Individual norovirus strains may be capable of infecting only a subset of the human population, although the diverse binding profiles found within genogroup I and genogroup II viruses likely collectively make nearly all individuals susceptible to norovirus infection.  Recurrent infections can occur throughout life because of the great diversity of norovirus strains and the lack of cross-strain or long-term immunity.
Infection is characterized by damage to the microvilli in the small intestine. Upon microscopic investigation, villi are found to be blunted, although the mucosa and epithelium remain intact.  A recent study demonstrated increased epithelial cell apoptosis and damage to tight junction proteins.  Diarrhea is induced by D-xylose and fat malabsorption, with enzymatic dysfunction observed at the brush border, along with leak flux and anion secretion. [14, 13] Vomiting is related to virus-mediated changes in gastric motility and delayed gastric emptying. Notably, no histopathologic lesions can be identified in the gastric mucosa of infected patients.  Noroviruses do not invade the colon, so fecal leukocytes are typically absent, and hematochezia is rare.
According to a Centers for Disease Control and Prevention (CDC) report updated in December 2014, each year on average in the United States, norovirus causes 19-21 million cases of acute gastroenteritis (inflammation of the stomach or intestines or both), leads to 1.7-1.9 million outpatient visits and 400,000 emergency department visits (primarily in young children), and contributes to about 56,000-71,000 hospitalizations and 570-800 deaths (mostly among young children and elderly persons). 
Norovirus illness can be acquired at any time during the year, but it is most common in winter. In addition, there can be 50% more norovirus illness cases in years when a new strain of the virus is being circulated.
According to surveillance reports prepared by CDC’s OutbreakNet team, in 2006, 1,270 reported foodborne outbreaks resulted in 27,634 illnesses and 11 deaths. Among these 1,270 outbreaks, 621 had a single confirmed cause that was most often norovirus (54% of outbreaks), followed by Salmonella species (18% of outbreaks). 
Outbreaks have been reported in restaurants, health care facilities, schools, resorts, cruise ships, military ships, and barracks. Viral transmission occurs year-round, with a higher incidence of disease in winter months in temperate climates. 
Data regarding outbreaks in developing nations are not well quantified, but the outbreak rate in other industrial nations is similar to that of the United States.
Norovirus gastroenteritis typically lasts 24-72 hours, with remission occurring without sequelae. Death is extremely rare, except in individuals particularly vulnerable to profound volume depletion.
Norovirus gastroenteritis can occur in individuals of all ages. Studies using norovirus recombinant antigen have suggested an increase in antibody prevalence with advancing age. In one study, the prevalence of norovirus immunoglobulin G (IgG) rose during school-aged years, reaching a peak of 70% in persons aged 11-16 years.  It should be noted, however, that not all infected individuals sustain detectable antibody responses.
Norovirus gastroenteritis is a self-limiting disease with an excellent prognosis in otherwise healthy individuals.
Patients with norovirus infection should be educated on personal and environmental hygiene, including avoiding/eliminating contaminated foods and water. Ill individuals should refrain from attending school or work.
Tian P, Mandrell R. Detection of norovirus capsid proteins in faecal and food samples by a real time immuno-PCR method. J Appl Microbiol. 2006 Mar. 100(3):564-74. [Medline].
Brinker JP, Blacklow NR, Jiang X, Estes MK, Moe CL, Herrmann JE. Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection. J Clin Microbiol. 1999 Sep. 37(9):2983-6. [Medline]. [Full Text].
Lowes R. New Norovirus Strain Hits US. Medscape Medical News. Jan 24 2013. [Full Text].
CDC. Notes from the Field: Emergence of New Norovirus Strain GII.4 Sydney—United States, 2012. MMWR. Jan 25 2013. 62(3):55. [Full Text].
Shoemaker GK, van Duijn E, Crawford SE, Uetrecht C, Baclayon M, Roos WH, et al. Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics. 2010 Aug. 9(8):1742-51. [Medline]. [Full Text].
Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology. 1993 Jul. 195(1):51-61. [Medline].
Ando T, Noel JS, Fankhauser RL. Genetic classification of “Norwalk-like viruses. J Infect Dis. 2000 May. 181 Suppl 2:S336-48. [Medline].
Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006 Mar 15. 346(2):312-23. [Medline].
Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev. 2008 Oct. 225:190-211. [Medline].
Huang P, Farkas T, Marionneau S, Zhong W, Ruvoën-Clouet N, Morrow AL, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. 2003 Jul 1. 188(1):19-31. [Medline].
Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med. 1973 Jun 21. 288(25):1318-23. [Medline].
Troeger H, Loddenkemper C, Schneider T, Schreier E, Epple HJ, Zeitz M, et al. Structural and functional changes of the duodenum in human norovirus infection. Gut. 2009 Aug. 58(8):1070-7. [Medline].
Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann Intern Med. 1972 Jun. 76(6):993-1008. [Medline].
Widerlite L, Trier JS, Blacklow NR, Schreiber DS. Structure of the gastric mucosa in acute infectious bacterial gastroenteritis. Gastroenterology. 1975 Mar. 68(3):425-30. [Medline].
Centers for Disease Control and Prevention (CDC). Norovirus: U.S. Trends and Outbreaks. Available at http://www.cdc.gov/norovirus/trends-outbreaks.html. December 30, 2014;
Norovirus and Salmonella were Leading Causes of Foodborne Disease Outbreaks in 2006. Available at http://www.cdc.gov/media/pressrel/2009/r090611.htm.
Mounts AW, Ando T, Koopmans M, Bresee JS, Noel J, Glass RI. Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis. 2000 May. 181 Suppl 2:S284-7. [Medline].
Parker SP, Cubitt WD, Jiang XJ, Estes MK. Seroprevalence studies using a recombinant Norwalk virus protein enzyme immunoassay. J Med Virol. 1994 Feb. 42(2):146-50. [Medline].
Rockx B, De Wit M, Vennema H, Vinjé J, De Bruin E, Van Duynhoven Y, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002 Aug 1. 35(3):246-53. [Medline].
Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect. 2006 Jan. 12(1):69-74. [Medline].
Ito S, Takeshita S, Nezu A, Aihara Y, Usuku S, Noguchi Y, et al. Norovirus-associated encephalopathy. Pediatr Infect Dis J. 2006 Jul. 25(7):651-2. [Medline].
Sugimoto T, Ogawa N, Aoyama M, Sakaguchi M, Isshiki K, Kanasaki M, et al. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. 2007 Jul. 22(7):2098-9. [Medline].
Guerrant RL, Shields DS, Thorson SM. Evaluation and diagnosis of acute infectious diarrhea. Am J Med. 1985 Jun 28. 78(6B):91-8. [Medline].
Boxman I, Dijkman R, Verhoef L, Maat A, van Dijk G, Vennema H, et al. Norovirus on swabs taken from hands illustrate route of transmission: a case study. J Food Prot. 2009 Aug. 72(8):1753-5. [Medline].
Cheng VC, Tai JW, Ho YY, Chan JF. Successful control of norovirus outbreak in an infirmary with the use of alcohol-based hand rub. J Hosp Infect. 2009 Aug. 72(4):370-1. [Medline].
Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol. 2010 Jan. 76(2):394-9. [Medline]. [Full Text].
Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006 Jun. 35(2):275-90, viii. [Medline].
Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med. 1991 Jul 25. 325(4):252-64. [Medline].
Centers for Disease Control and Prevention (CDC). Multisite outbreak of norovirus associated with a franchise restaurant–Kent County, Michigan, May 2005. MMWR Morb Mortal Wkly Rep. 2006 Apr 14. 55(14):395-7. [Medline].
Centers for Disease Control and Prevention (CDC). Norovirus outbreak among evacuees from hurricane Katrina–Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep. 2005 Oct 14. 54(40):1016-8. [Medline].
Centers for Disease Control and Prevention (CDC). Outbreaks of gastroenteritis associated with noroviruses on cruise ships–United States, 2002. MMWR Morb Mortal Wkly Rep. 2002 Dec 13. 51(49):1112-5. [Medline].
[Guideline] DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997 Nov. 92(11):1962-75. [Medline].
Graham DY, Jiang X, Tanaka T. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. 1994 Jul. 170(1):34-43. [Medline].
Greenberg HB, Valdesuso J, Yolken RH. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis. 1979 May. 139(5):564-8. [Medline].
Jiang X, Wang M, Graham DY. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992 Nov. 66(11):6527-32. [Medline].
Jääskeläinen AJ, Maunula L. Applicability of microarray technique for the detection of noro- and astroviruses. J Virol Methods. 2006 Sep. 136(1-2):210-6. [Medline].
Kaplan JE, Gary GW, Baron RC. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med. 1982 Jun. 96(6 Pt 1):756-61. [Medline].
Moe CL, Gentsch J, Ando T. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol. 1994 Mar. 32(3):642-8. [Medline].
Zartash Zafar Khan, MD, FACP Infectious Disease Consultant
Disclosure: Nothing to disclose.
Todd S Wills, MD Associate Professor, Department of Medicine, Division of Infectious Disease and International Medicine, Program Director, Infectious Disease Fellowship Program, University of South Florida College of Medicine
Todd S Wills, MD is a member of the following medical societies: Infectious Diseases Society of America
Disclosure: Nothing to disclose.
Michelle A Jaworski, MD Consulting Staff, Midland Orthopedic Associates
Disclosure: Nothing to disclose.
Mark Martin Huycke, MD Professor of Medicine, Infectious Diseases Section, University of Oklahoma Health Sciences Center; Chief, Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City
Mark Martin Huycke, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association for Cancer Research, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Infectious Diseases Society of America
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Richard B Brown, MD, FACP Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine
Richard B Brown, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, Massachusetts Medical Society
Disclosure: Nothing to disclose.
Mark R Wallace, MD, FACP, FIDSA Clinical Professor of Medicine, Florida State University College of Medicine; Clinical Professor of Medicine, University of Central Florida College of Medicine
Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, Florida Infectious Diseases Society
Disclosure: Nothing to disclose.
Joseph R Masci, MD, FACP, FCCP Professor of Medicine, Professor of Preventive Medicine, Icahn School of Medicine at Mount Sinai; Director of Medicine, Elmhurst Hospital Center
Joseph R Masci, MD, FACP, FCCP is a member of the following medical societies: American Association for the Advancement of Science, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, International AIDS Society, International Society for Infectious Diseases, New York Academy of Medicine, New York Academy of Sciences, Physicians for Social Responsibility, Royal Society of Medicine, Association of Program Directors in Internal Medicine, Physicians for Human Rights, Association of Professors of Medicine, HIV Medicine Association, American Academy of HIV Medicine, Association of Specialty Professors, International Association of Providers of AIDS Care, Federation of American Scientists, American Society of Tropical Medicine and Hygiene
Disclosure: Nothing to disclose.
Research & References of Norovirus|A&C Accounting And Tax Services